Format

Send to

Choose Destination
See comment in PubMed Commons below
Surg Oncol Clin N Am. 2008 Oct;17(4):877-94, xi. doi: 10.1016/j.soc.2008.04.007.

Isolated hepatic perfusion for the treatment of liver tumors: sunset or sunrise?

Author information

1
Department of Surgical Oncology, Erasmus University Medical Centre-Daniel den Hoed Cancer Centre, Rotterdam, The Netherlands.

Abstract

Experience with isolated hepatic perfusion (IHP) is limited to a few centers in the world because of the technical difficulties, surgery-related morbidity, and unproved efficacy in randomized trials. Experimental animal IHP models have led to exploring new ways of improving efficacy, reducing technical difficulties, and minimizing regional and systemic toxicity. Future research should be directed to the identification of suitable biologic or chemotherapeutic agents, defining clinical indications, and development of technical modifications to make it more generally applicable and even repeatable.

PMID:
18722924
DOI:
10.1016/j.soc.2008.04.007
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Support Center